Technology News and Research

RSS

Three Johns Hopkins scientists receive NIH Director's New Innovator Awards

A pioneer in the field of epigenetics who has been spearheading the use of genome-wide technology for epigenetics research, a researcher who has revealed a weakness in the tuberculosis bacterium that makes it more susceptible to antibiotics, and a scientist who seeks to revolutionize new methods for toxicological testing to improve human health and reduce animal testing have received Director's Awards from the National Institutes of Health.

22 Sep 2011

NIH-funded project to develop new class of tissue regeneration therapeutics

The National Institutes of Health (NIH) has awarded nearly $2 million to researchers at the Georgia Institute of Technology and Emory University to develop a new class of therapeutics for treating traumatic injuries and degenerative diseases.

22 Sep 2011

Viewpoints: Progressives relish fight for 'shared sacrifice;' Desmond Tutu seeks to renew battle against HIV

To get our books in order, Obama would raise taxes on the rich while gaining savings by ending the wars abroad and reducing Medicare and Medicaid's unnecessarily high payments to drug companies. Republicans rise in defense of tax cuts for the wealthy and insist that deficit reduction come solely from cuts in Social Security, Medicare and Medicaid and other "entitlements." The president stands for shared sacrifice; the Republicans for sheltering the privileged few. Progressives will have no problem standing with the president in this fight.

22 Sep 2011

Converting genetic data into biomedical knowledge a true challenge for statisticians

Within a decade, a combination of advanced measurement techniques and statistics will enable scientists to develop methods to diagnose serious diseases caused by genetic defects. Ten years after that, there may be medicines available to repair these defects.

21 Sep 2011

IRIDEX licenses rights to Ocunetics' intellectual property

IRIDEX Corporation today announced that it has exclusively licensed the rights to all of the intellectual property of Ocunetics, Inc., a privately held company based in Alamo, California. Ocunetics develops procedure-enabling medical devices that are intended to increase surgeons' efficiency, while improving case predictability for ophthalmic surgeries.

21 Sep 2011

Influential leaders hold high-level discussions on biomedical S&T initiatives

Influential leaders from the medical and research communities held high-level discussions on biomedical science and technology (S&T) initiatives at the Office of Naval Research (ONR), Sept. 16.

21 Sep 2011

Positive data from InVivo's biomaterial scaffold implant preclinical study on acute SCI

InVivo Therapeutics Holdings Corp., a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that in a rodent contusion model of SCI the Company's proprietary biopolymer scaffold showed positive preliminary data that indicate a therapeutic effect.

21 Sep 2011

Clinical trial to evaluate TAU's stem cell technology for ALS

The ability to produce neuroprotectors, proteins that protect the human brain against neurodegenerative disorders such as Parkinson's and ALS, is the holy grail of brain research. A technology developed at Tel Aviv University does just that, and it's now out of the lab and in hospitals to begin clinical trials with patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

21 Sep 2011

St. Jude Medical pledges $100,000 to support SIR Foundation's Discovery Campaign

The Society of Interventional Radiology Foundation's Discovery Campaign, which seeks to further the growth of minimally invasive medicine into new areas of discovery, announced a major corporate pledge to that initiative. St. Jude Medical Foundation, the philanthropic arm of St. Jude Medical, has pledged $100,000 and is a "Pioneer" level supporter.

21 Sep 2011

ASU scientists receive USDA grants to combat food-related illness

Roughly 1 in six Americans are sickened every year by food-borne ailments, according to the Centers for Disease Control and Prevention. The effects of these illnesses range from acutely unpleasant to lethal, and the problem may be getting worse, as our food supply becomes more global, with an increasing number of antibiotic-resistant pathogens.

21 Sep 2011

World leaders should commit to closing health care worker gap

Recent U.N. statistics showing a drop in child mortality are both good and bad, because the number of child deaths continues to drop, but "progress isn't reaching all families around the world, and it isn't reaching newborn babies as often as older children," Joy Lawn, director of Global Evidence and Policy for Save the Children's Saving Newborn Lives program, writes in a GlobalPost opinion piece.

21 Sep 2011

CRANN partnership with Merck Millipore on research

CRANN, the Science Foundation Ireland funded nanoscience research institute, based at Trinity College Dublin, has today announced a new commercial partnership worth over €130,000 with Merck Millipore, a biotech and pharmaceutical company based in Cork. As part of the research programmes, CRANN will assist Merck Millipore to further develop the nanostructures of their products’ artificial membranes, that are widely used for medical and diagnostic devices, and to deliver new products with improved membrane performances. Artificial membranes are used in a wide array of products such as lab filtration devices, antibody screening kits and blood typing products.

21 Sep 2011

Enrollment complete in STENTYS Self-Apposing Stent clinical study for treatment of AMI

STENTYS S.A., a medical technology company that is commercializing the world's first and only self-apposing stent to treat Acute Myocardial Infarction (AMI), announced today that it has enrolled the 500-patient target of the international APPOSITION III study for its Self-Apposing Stent.

21 Sep 2011

Smith & Nephew's TRUCLEAR System to improve training for gynecologists

Smith & Nephew plc, the global medical technology business, today announced the introduction of its TRUCLEAR SIM Morcellation Simulator, a highly-realistic, hands-on simulator designed to improve training for gynecologists who perform hysteroscopic morcellation, a procedure to remove intrauterine polyps and fibroids.

21 Sep 2011

Positive results from Orexo's OX219 clinical study on opioid dependence

Orexo AB (STO:ORX) today announced that it has obtained positive results in a clinical study with OX219, which is being developed for the treatment of opioid dependence.

21 Sep 2011

Silence Therapeutics reports revenue of £354,078 for six months ended 30 June 2011

Silence Therapeutics Plc, a leading international RNAi therapeutics company, today provides a corporate update and announces its interim results for the six months ended 30 June 2011.

21 Sep 2011

Researchers can reverse aging process for human adult stem cells

Researchers have shown they can reverse the aging process for human adult stem cells, which are responsible for helping old or damaged tissues regenerate.

21 Sep 2011

Financial and political commitments to improve health of women and children

In only one year, more than 100 countries, foundations, multilateral organizations, the UN, the private sector, and academic and professional associations have made unprecedented financial and political commitments to greatly improve the health of women and children.

21 Sep 2011

Tips for parents to keep their family physically fit and healthy

Pick up any newspaper, magazine or online publication and news about obesity is everywhere. While some parents feel helpless in the fight to keep their family physically fit and healthy, other parents are taking action. Studies show that exercising as a family not only promotes good health but also helps strengthen the emotional bonds between family members.

21 Sep 2011

NIH to honor two Scripps Research scientists with innovator awards

Two Scripps Research Institute scientists have won prestigious National Institutes of Health (NIH) Director's New Innovator Awards. The recipients are Assistant Professor Michael Petrascheck of the institute's La Jolla, California campus, and Assistant Professor Brian Paegel of the Jupiter, Florida campus.

21 Sep 2011